Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
2002-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Octreotide may help doxorubicin kill more cancer cells by making
tumor cells more sensitive to the drug.
PURPOSE: Phase I trial to study the effectiveness of octreotide and doxorubicin in treating
patients who have advanced cancer.